These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 91570)

  • 21. Heating at 56 degrees C does not eliminate immune complex-bound Clq.
    Teppo AM; Wager O
    Scand J Immunol; 1979; 10(5):431-5. PubMed ID: 545666
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Purification of the first component of guinea-pig complement by gel chromatography.
    Lyberg T
    Acta Pathol Microbiol Scand C; 1978 Dec; 86C(6):283-9. PubMed ID: 103366
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Purification and characterization of equine relaxin.
    Stewart DR; Papkoff H
    Endocrinology; 1986 Sep; 119(3):1093-9. PubMed ID: 3732157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glutamic dehydrogenase from rat heart mitochondria. I. Purification and physical properties including molecular weight determination.
    McDaniel HG; Yeh M; Jenkins R; Razzaque A
    J Mol Cell Cardiol; 1984 Apr; 16(4):295-301. PubMed ID: 6726819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isolation of human C1q as a by-product of routine fractionation.
    Granier C; Faure A; Tavernier R; Steinbuch M
    Prep Biochem; 1979; 9(3):281-91. PubMed ID: 471943
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Fibronectin associated with Clq in a Clq isolation procedure.
    Anderson B; Entwistle R; Puyat L; Davis L; Schmid FR
    Immunol Commun; 1981; 10(8):687-96. PubMed ID: 6804372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential elution of Clq, Clr and Cls from human Cl bound to immune aggregates. Use in the rapid purification of Cl subcomponents.
    Arlaud GJ; Sim RB; Duplaa AM; Colomb MG
    Mol Immunol; 1979 Jul; 16(7):445-50. PubMed ID: 40870
    [No Abstract]   [Full Text] [Related]  

  • 28. Crystallization and properties of creatine kinase from equine skeletal muscle.
    Takasawa T; Fukushi K; Shiokawa H
    J Biochem; 1981 May; 89(5):1619-31. PubMed ID: 7275956
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ultracentifuge studies of the binding of IgG of different subclasses to the Clq subunit of the first component of complement.
    Schumaker VN; Calcott MA; Spiegelberg HL; Müller-Eberhard HJ
    Biochemistry; 1976 Nov; 15(23):5175-81. PubMed ID: 990273
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-density lipoprotein that supports Ureaplasma urealyticum growth.
    Sayed IA; Sweat FW
    J Bacteriol; 1982 Aug; 151(2):629-35. PubMed ID: 7201468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Isolation and characterization of highly stable rabbit C1q.
    Paul SM; Liberti PA
    J Immunol Methods; 1978; 21(3-4):341-53. PubMed ID: 670717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Solvent effects on the structure of rabbit Clq, a subcomponent of the first component of complement.
    Paul SM; Baillie RD; Liberti PA
    J Biol Chem; 1978 Aug; 253(16):5658-64. PubMed ID: 27519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction of human Clq with insoluble immunoglobulin aggregates.
    Lin TY; Fletcher DS
    Immunochemistry; 1978 Feb; 15(2):107-17. PubMed ID: 24581
    [No Abstract]   [Full Text] [Related]  

  • 34. C-reactive protein in eel: purification and agglutinating activity.
    Nunomura W
    Biochim Biophys Acta; 1991 Jan; 1076(2):191-6. PubMed ID: 1900197
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A simple method for the preparation and purification of C1 complement cleaved beta 2-microglobulin from human serum.
    Nissen MH; Johansen B; Bjerrum OJ
    J Immunol Methods; 1997 Jun; 205(1):29-33. PubMed ID: 9236912
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isolation and partial characterization of bovine and equine factor D.
    Blanchard DB; Leid RW
    Mol Immunol; 1984 Oct; 21(10):869-76. PubMed ID: 6568410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ultrastructure of the human complement component, Clq (negative staining-glutamine synthetase-biologically active Clq).
    Shelton E; Yonemasu K; Stroud RM
    Proc Natl Acad Sci U S A; 1972 Jan; 69(1):65-8. PubMed ID: 4109599
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunoprecipitation of proteins from cell-free translations.
    Anderson DJ; Blobel G
    Methods Enzymol; 1983; 96():111-20. PubMed ID: 6361451
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The activation of mutant beta-galactosidase by specific antibodies. Purification of eleven antibody activatable mutant proteins and their subunits on sepharose immunosorbents. Determination of the molecular weights by sedimentation analysis and acrylamide gel electrophoresis.
    Melchers F; Messer W
    Eur J Biochem; 1970 Dec; 17(2):267-72. PubMed ID: 5500395
    [No Abstract]   [Full Text] [Related]  

  • 40. Clq, the first component of complement, binds to activated human platelets.
    Elendt D; Kirsch K; Malberg K
    Platelets; 1991; 2(1):51-2. PubMed ID: 21043962
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.